Brand name: Actos
Public Citizen has been assessing the quality and efficacy of drugs and devices since its founding in 1971. We use the law, petitions, and letters to monitor the FDA and coax the agency into action. Our actions have contributed to many drugs being pulled off the market. Public Citizen has also been instrumental in getting “black box” and other warnings on drugs. Our advocacy work on this drug is available below.
If you are interesting in reading our evaluations of the safety and efficacy of medications as well as information on drug side effects and interactions, please visit WorstPills.org.
More Information on Pioglitazone (Actos)
- Testimony on Rosiglitazone (Avandia), April 28, 2010
- Life-Threatening Liver Toxicity of Avandia (Rosiglitazone) Shown in New Public Citizen Research Published in Peer-Reviewed Medical Journal, July 22, 2009
- Letter in the Lancet on the Availability of Information on Thiazolidinediones, July 15, 2000
- Petition Requesting Updated Labeling for Diabetes Drugs Troglitazone (Rezulin), Rosiglitazone (Avandia) and Pioglitazone (Actos), March 7, 2000